Woman sues troubled radiology practice over mammography quality issues

A woman from Wake County, North Carolina, is suing a radiology practice that previously suspended its mammography testing over issues with image quality.

The clinic—Raleigh Radiology Blue Ridge—was forced to suspend its breast screening exams after an investigation by the Food and Drug Administration and American College of Radiology revoked its accreditation.

Emily Cram filed a lawsuit in Wake Superior Court against the Blue Ridge office alleging she underwent three mammograms at the facility during the two-year period officials investigated. The lawsuit states that Cram wasn’t told if her images were among the exams performed from Nov. 7, 2017, to Nov. 6, 2019, which were later reviewed by the FDA.

Lawyers are seeking class action status for the suit to incorporate other women who had breast scans during the two-year period, according to a Jan. 7 report from the Raleigh News & Observer. Cram also wants a refund for breast cancer screenings performed, along with repayment for costs incurred during repeat mammograms.

As part of the FDA review, the agency found most of the mammography images were acceptable. Raleigh Radiology released a statement Dec. 17 saying there were no instances of missed cancer or any other disease.

 

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.